ESR1 and breast carcinoma: Since three breast cancer cell lines (T47D, MCF-7 and BT-483) used in this study are classified as Luminal A estrogen receptor+ (ER+), PR+, HER2-, invasive ductal carcinoma, we tested whether these data are specific to this type of tumor by using ER knockdown T47D.